Aifstira IV 2500 is an injectable drug containing Lonoctocog alpha (genetical recombination), manufactured by CSL Behring. It has a YJ code of 6343450D6029 and a standard of 2,500 IU x 1 bottle (with dissolving solution).
Aifstira IV 2500
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).